Reaction Details Report a problem with these data
Target
Interleukin-2
Ligand
BDBM412397
Substrate
n/a
Meas. Tech.
Human ELISA assay
IC50
26.0±n/a nM
Citation
 Chen, S; Bohnert, G; Jiang, J; Xia, Z Compounds for inflammation and immune-related uses US Patent  US10399967 Publication Date 9/3/2019 
Target
Name:
Interleukin-2
Synonyms:
IL-2 | IL2 | IL2_HUMAN | INN=Aldesleukin | Interleukin-2 | Interleukin-2 (IL-2) | T-cell growth factor | TCGF
Type:
Enzyme
Mol. Mass.:
17630.05
Organism:
Homo sapiens (Human)
Description:
P60568
Residue:
153
Sequence:
MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT
  
Inhibitor
Name:
BDBM412397
Synonyms:
N-(5-(2-ethyl-5-(2-methyl-2H- tetrazol-5-yl)phenyl)pyrazin-2-yl)-5- fluoro-4-methylnicotinamide | US10399967, Compound 27
Type:
Small organic molecule
Emp. Form.:
C21H19FN8O
Mol. Mass.:
418.427
SMILES:
CCc1ccc(cc1-c1cnc(NC(=O)c2cncc(F)c2C)cn1)-c1nnn(C)n1
Structure:
Search PDB for entries with ligand similarity: